Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd (SHA:600721)
China flag China · Delayed Price · Currency is CNY
11.80
-1.06 (-8.24%)
Sep 3, 2026, 3:00 PM CST

SHA:600721 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
343.33387.43383.47366.22346.37278.13
Other Revenue
0.260.892.283.063.513.22
343.59388.32385.76369.28349.88281.35
Revenue Growth
-12.25%0.66%4.46%5.54%24.36%232.84%
Cost of Revenue
207.66237.1224.05227.84255.43184.18
Gross Profit
135.93151.22161.71141.4494.4597.17
Selling, General & Admin
66.4167.1668.473.7278.3564.51
Research & Development
21.4724.3829.5531.8727.485.25
Other Operating Expenses
5.055.135.225.254.794.65
Operating Expenses
86.54101.19131.11127.3127.1683.14
Operating Income
49.3850.0330.5914.14-32.7114.04
Interest Expense
-----0.11-0.05
Interest & Investment Income
0.411.114.962.270.520.22
Currency Exchange Gain (Loss)
-0.07-0.07-0.05-0--
Other Non Operating Income (Expenses)
-6.07-0.020.57-0.6-0.66-0.37
EBT Excluding Unusual Items
43.6651.0636.0715.81-32.9713.84
Gain (Loss) on Sale of Investments
-7.39-7.3-0.130.70.010.44
Gain (Loss) on Sale of Assets
000.090.0100.01
Asset Writedown
-6.74-0.28-0.1-0.39-0.07-0.13
Legal Settlements
-0.61-0.84-0.38-0.11-0.11-0.3
Other Unusual Items
1.411.521.30.451.0248.32
Pretax Income
30.3344.1636.8616.48-32.1262.18
Income Tax Expense
0.363.47-4.613.512.622.3
Earnings From Continuing Operations
29.9640.6941.4812.97-34.7459.87
Minority Interest in Earnings
-----0.03-0.05
Net Income
29.9640.6941.4812.97-34.7659.83
Net Income to Common
29.9640.6941.4812.97-34.7659.83
Net Income Growth
-32.36%-1.91%219.75%---
Shares Outstanding (Basic)
384384382379376375
Shares Outstanding (Diluted)
384384382379376375
Shares Change
0.13%0.50%0.79%0.92%0.20%-3.79%
EPS (Basic)
0.080.110.110.03-0.090.16
EPS (Diluted)
0.080.110.110.03-0.090.16
EPS Growth
-32.45%-2.40%217.25%---

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
22.2512.4255.6844.8450.7728.68
Free Cash Flow Per Share
0.060.030.150.120.140.08
Dividend Per Share
0.0400.040----
Dividend Growth
------
Gross Margin
39.56%38.94%41.92%38.30%27.00%34.54%
Operating Margin
14.37%12.88%7.93%3.83%-9.35%4.99%
Profit Margin
8.72%10.48%10.75%3.51%-9.94%21.26%
Free Cash Flow Margin
6.48%3.20%14.44%12.14%14.51%10.20%
EBITDA
67.9767.8448.935.41-7.1339.18
EBITDA Margin
19.78%17.47%12.68%9.59%-2.04%13.93%
D&A For EBITDA
18.5817.8118.321.2725.5825.14
EBIT
49.3850.0330.5914.14-32.7114.04
EBIT Margin
14.37%12.88%7.93%3.83%-9.35%4.99%
Effective Tax Rate
1.20%7.87%-21.29%-3.70%
Revenue as Reported
186.23388.32385.76369.28349.88281.35
Advertising Expenses
-1.350.141.090.840.4